February 2020 Update — A former Canada-wide class action was commenced against a drug manufacturer (GlaxoSmithKline) which alleged that using Avodart can cause high grade prostate cancer, and permanent or temporary sexual dysfunction. These allegations were not been proven in Court. The Avodart class action has been discontinued.
Although GlaxoSmithKline has denied any liability, GlaxoSmithKline has agreed to attempt to settle (on an individual basis) certain qualifying legal claims made by Canadian residents who have used Avodart and subsequently been diagnosed with high grade prostate cancer. The same individual settlement process is currently underway (as of February 2020) and the deadline to apply for individual compensation has not yet been set by the Courts, but the deadline to apply under this process is expected to expire in March, 2021.
For more information, you should immediately email our office at: Avodart@merchantlaw.com with details regarding your high grade prostate cancer and Avodart usage. Please also provide your full contact information. Please also visit this webpage each month, for any general updates. [You may also call our law office for a free initial consultation without obligation, at 306-653-7756, regarding compensation claims anywhere in Canada.]